Vidacare Corporation’s EZ-IO Intraosseous Vascular Access System Reaches Growth Milestone With Two Million Needle Sets Sold
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN ANTONIO--(BUSINESS WIRE)--Vidacare Corporation announced today that it has surpassed sales of two million EZ-IO® Intraosseous Vascular Access System needle sets, marking a new growth milestone for the company. Vidacare attributes this achievement to continued acceptance and increased adoption of intraosseous vascular access across multiple medical platforms in parallel with the company’s strategic global expansion efforts.
Help employers find you! Check out all the jobs and post your resume.
SAN ANTONIO--(BUSINESS WIRE)--Vidacare Corporation announced today that it has surpassed sales of two million EZ-IO® Intraosseous Vascular Access System needle sets, marking a new growth milestone for the company. Vidacare attributes this achievement to continued acceptance and increased adoption of intraosseous vascular access across multiple medical platforms in parallel with the company’s strategic global expansion efforts.
Help employers find you! Check out all the jobs and post your resume.